School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

REPLIGEN CORP RGEN

Healthcare · Medical Instruments & Supplies

$173.88last close 2026-10-09 · market cap $11.04B · delayed data

Trailing returns

1M+5.35%
3M+20.80%
6M+45.17%
1Y+16.85%
5Y-32.81%

Basis: Adjusted daily closes.

What it does

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Open RGEN in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies